Enviro Voraxial Technology, Inc. (EVTN) Announces Multi-Unit Purchase Order for Voraxial® Separator
Enviro Voraxial Technology today announced it has received and shipped another multi-unit purchase order for its patented Voraxial® Separator, an…
Blog
eCrypt Technologies, Inc. (ECRY) Offers Comprehensive, Easy-to-Use Solutions to Protect Sensitive Data
eCrypt has built a robust security platform for military-grade strong encryption that the average consumer can use with ease, extending…
Poynt Corp. (PNYTF) is “One to Watch”
Poynt Corp. is a mobile local search and advertising company. The company's flagship product is Poynt Local Search. This is…
DayStar Technologies, Inc. (DSTI) Video Chart for Wednesday, March 7, 2012
DSTI has been in a channel between 50 cents and 22 cents for four months. After falling from the top…
CUI Global, Inc. (CUGI) Closes Over Allotment Provision, Gains $1.5M
CUI Global, Inc. announced that it has closed the Over Allotment provision in its underwriting agreement, filed with assistance from…
Digerati Technologies, Inc. (DTGI) Makes Direct Dialing Service Available Worldwide
Yesterday, Digerati Technologies announced that its direct inward dialing (DID) service is now available to customers in over 50 countries.…
Cytokinetics, Inc. (CYTK) Receives Orphan Drug Designation from European Medicines Agency
Cytokinetics, a clinical-stage biopharm company developing novel small molecule therapeutics for the potential treatment of serious diseases and medical conditions,…
Premier Power Renewable Energy, Inc. (PPRW) Begins Construction of Bulgaria Solar Power Plant Project
Premier Power Renewable Energy, a global provider of large and medium-scale solar power systems, today announced it has commenced the…
Marley Coffee (JAMN) Announces New Sales Leadership in Canada
Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced the addition of Raymond Pahlad as…
Marshall Edwards, Inc. (MSHL) Cancer Drug Success Continues, IND Submitted to FDA for ME-344, Advances Made in ME-143 Trials
Today, Marshall Edwards, which is steadily breaking new ground in the field of cancer therapeutics via naturally occurring isoflavone compounds…